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The effects of Cisplatin on human 
diploid fibroblast cells expressing 
SV40 T-antigen 
Can we predict Cisplatin resistance/sensitivity based on BIN1 
protein isoform present?
Emma Shangraw
 Bridging integrator 1
 Nucleocytoplasmic tumor suppressor protein
 Halt the cell cycle
 Ubiquitous expression in all cell types
 Variant isoforms across cell types
 Myc binding domain
 Important for BIN1 mediated apoptosis
 Complete and partial losses of BIN1 documented in 60% breast cancer cases
BIN1
c-Myc and PARP1
 cellular-Myc:
 Proto-oncogene 
 Overexpression leads to increased cell proliferation
 Poly(ADP-ribose)polymerase-1
 Enzyme responsible for fixing double and single stranded DNA 
breaks
 Overexpressed in wide range of cancers
Cisplatin
 Chemotherapeutic drug
 Activated once taken up by cell
 Water ions in the cytoplasm displace Cl-
 Binds to N7 reactive centers on purine to 
cause DNA damage
 Very effective against a wide range of 
cancers
 Drug resistance and side effects
 Nephro- and hepatotoxicity 
Apoptosis
 Programmed cell death
 Caspase independent (protein damage)
 Inner mitochondrial membrane dissipates 
 Release apoptosis inducing factor (AIF)
 Caspase-dependent (DNA damage)
 Extrinsic 
 Received signal, activate Caspase 8
 Effector caspases cause nuclear damage
 Intrinsic (p-53 independent)
 Reactive Oxygen species activate Bcl-2 family releasing cytochrome 
c from the mitochondria
Cisplatin-
sensitive vs 
Cisplatin-
resistant
Apoptosis Apoptosis
Hypothesis
 Unsure of BIN1 isoform present
 Determine functionally if there was a difference in cisplatin sensitivity across 
variant isoforms
Methods
 Human diploid fibroblast (HDF) cells
 Immortalized with telomerase 
 Stably transfected with SV40 T-antigen  (HDF+T)
 2 Clones
 Seeded cells of each 3 lines in triplicate and conducted a dose curve
 0.0, 0.5, 1.0, 2.0 ug/ml
 Counted cells 3 days after dosage to determine percentage of cell death 
 Immunofluorescence and Western blot analysis to determine presence of BIN1
Percent change over 3 days
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Future Experiments
 Determine apoptosis vs necrosis
 Test known Cisplatin resistant cells and determine their isoform
 Probe Western blot for PARP1
 Treat Cisplatin resistant cells with PARP1-inhibitors 
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